TFF Pharmaceuticals
Stock Forecast, Prediction & Price Target
TFF Pharmaceuticals Financial Estimates
TFF Pharmaceuticals Revenue Estimates
TFF Pharmaceuticals EBITDA Estimates
TFF Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $733.87K 0% | Avg: $300K Low: $258.92K High: $339.28K avg. -59.12% | Avg: $5.76M Low: $4.97M High: $6.51M avg. 1821.16% | Avg: $62.03M Low: $53.54M High: $70.15M avg. 976.30% | Avg: $61.05M Low: $52.69M High: $69.05M avg. -1.57% |
Net Income
% change YoY
| $-30.98M N/A | $-31.77M -2.52% | $-21.24M 33.13% | Avg: $-33.87M Low: $-11.65M High: $-2.29M avg. -59.48% | Avg: $-31.78M Low: $-8.98M High: $-1.88M avg. 6.17% | Avg: $-1.64M Low: $-1.92M High: $-1.35M avg. 94.81% | Avg: $4.56M Low: $3.75M High: $5.33M avg. 376.63% |
EBITDA
% change YoY
| $-31.67M N/A | $-31.40M 0.84% | $-20.74M 33.96% | Avg: $180K Low: $155.35K High: $203.57K avg. 100.86% | Avg: $3.45M Low: $2.98M High: $3.91M avg. 1821.16% | Avg: $37.21M Low: $32.12M High: $42.09M avg. 976.30% | Avg: $36.63M Low: $31.61M High: $41.43M avg. -1.57% |
EPS
% change YoY
| -$31.21 N/A | -$26.49 15.12% | -$11.85 55.26% | Avg: -$3.89 Low: -$6.5 High: -$1.28 avg. 67.17% | Avg: -$3.03 Low: -$5.01 High: -$1.05 avg. 22.10% | Avg: -$0.92 Low: -$1.08 High: -$0.76 avg. 69.63% | Avg: $2.55 Low: $2.09 High: $2.98 avg. 376.63% |
Operating Expenses
% change YoY
| $31.78M N/A | $31.79M 0.03% | $22.62M -28.83% | Avg: $1.10M Low: $952.81K High: $1.24M avg. -95.12% | Avg: $21.20M Low: $18.30M High: $23.98M avg. 1821.16% | Avg: $228.27M Low: $197.01M High: $258.16M avg. 976.30% | Avg: $224.67M Low: $193.91M High: $254.09M avg. -1.57% |
FAQ
What is TFF Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 104.53% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -11.65M, average is -33.87M and high is -2.29M.
What is TFF Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 684.19% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $258.92K, average is $300K and high is $339.28K.
What is TFF Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 133.88% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$6.5, average is -$3.89 and high is $-1.28.